Jean-Jacques Muyembe-Tamfum

Jean-Jacques Muyembe-Tamfum is a Congolese physician, microbiologist and virologist known for Ebola outbreak investigation, therapeutic research and public-health leadership. Institutional sources identify him as Director General of the Institut National de Recherche Biomédicale in Kinshasa, while the University of Kinshasa lists him as a professor of medical biology.

Star Mover ranking

Not ranked in News yet

0 points

Sign in to Move Up

Profile

About Jean-Jacques Muyembe-Tamfum

Profile information current to 2026-08-22.

Democratic Republic of the Congo · Physician, Microbiologist, Virologist · 2 affiliations

Show full profile Hide full profile

Also known as: Jean-Jacques Muyembe, Jean-Jacques Muyembe-Tamfun
Known for: Ebola virus disease research and outbreak response; Microbiology and virology; Biomedical research capacity and infectious-disease response in the Democratic Republic of the Congo
Country: Democratic Republic of the Congo

Physician
Microbiologist
Virologist
University professor

At a glance

He is identified as Director General of the Institut National de Recherche Biomédicale, with Government of Japan biographical material dating his tenure from 1998.
He participated in the investigation of the 1976 Ebola outbreak at Yambuku, where a historical account says he led a Congolese team sent from Kinshasa.
An NIH record names him as a co-inventor of the anti-Ebola monoclonal antibody mAb114, and he was an author of the PALM Consortium therapeutic trial.
His honors include the 2019 Hideyo Noguchi Africa Prize for medical research and a 2023 WHO Director-General's Global Health Leaders Award.

Medical training and academic work

Muyembe-Tamfum received an M.D. from the University of Lovanium in 1969 and a Ph.D. in medicine and virology from the Rega Institute for Medical Research at the Catholic University of Leuven in 1973. The University of Kinshasa lists him as a full professor in the Faculty of Medicine's Department of Medical Biology, with microbiology and virology among his research fields.

Ebola outbreak investigation and response

His Ebola work extends from the first recognized outbreak in 1976 to later public-health responses. A historical scholarly account reports that a national team led by Muyembe-Tamfum was sent from Kinshasa to Yambuku on September 23, 1976, and other biographical sources document his participation in that investigation. He also took part in detection and control measures during the 1995 outbreak in Kikwit.

Therapeutic research

An NIH technology record identifies Muyembe-Tamfun as a co-inventor of mAb114, a human-derived monoclonal antibody for treating Ebola virus infection. Muyembe-Tamfum was also a listed author on the PALM Consortium trial, which found that mAb114 and REGN-EB3 were superior to ZMapp in reducing mortality from Ebola virus disease.

Institutional and public leadership

Institutional and biographical sources identify Muyembe-Tamfum as Director General of the Institut National de Recherche Biomédicale in Kinshasa, with Government of Japan material dating his tenure from 1998. His wider public roles include serving as the inaugural president of the Congolese Academy of Science. His contributions to medical research and global health have been recognized by the Hideyo Noguchi Africa Prize, the WHO Director-General's Global Health Leaders Award and an honorary doctorate from Sorbonne Université.

Affiliations

Institut National de Recherche Biomédicale Director General 1998–present
University of Kinshasa Full professor, Faculty of Medicine, Department of Medical Biology present

Timeline

1969 Received an M.D. from the University of Lovanium.
1973 Received a Ph.D. in medicine and virology from the Rega Institute for Medical Research at the Catholic University of Leuven.
1976-09-23 A national team led by Muyembe-Tamfum was sent from Kinshasa to investigate the Yambuku outbreak later identified as Ebola virus disease.
1995 Participated in detection and control measures during the Kikwit Ebola outbreak.
1998 Government of Japan biographical material dates his tenure as INRB General Director from 1998 onward.
2019 Received the Hideyo Noguchi Africa Prize in the Medical Research category.
2023-05-18 Named a recipient of the WHO Director-General's Global Health Leaders Award.
2025 Recognized as a Doctor Honoris Causa by Sorbonne Université.

Additional verified details

Current context

Jean-Jacques Muyembe-Tamfum is identified as Director General of the Institut National de Recherche Biomédicale in Kinshasa. The INRB institutional description and a 2025 Sorbonne Université profile support the role. The reviewed sources do not include a newer formal appointment instrument, fixed-term record or succession record.
The University of Kinshasa directory lists him as a full professor in the Faculty of Medicine's Department of Medical Biology, with research fields in microbiology and virology. The directory lists the role but does not provide a dated appointment or promotion record.

Biographical facts

He was born on March 17, 1942, in what is now the Democratic Republic of the Congo.
He received an M.D. from the University of Lovanium in 1969.
He received a Ph.D. in medicine and virology from the Rega Institute for Medical Research at the Catholic University of Leuven in 1973.
He participated in the investigation of the 1976 Ebola outbreak at Yambuku; a historical scholarly account reports that a national team led by him was sent from Kinshasa on September 23, 1976.
He took part in detection and control measures during the 1995 Ebola outbreak in Kikwit, Democratic Republic of the Congo.
An NIH technology record names Muyembe-Tamfun as a co-inventor of mAb114, and Muyembe-Tamfum was a listed author on the PALM Consortium trial that found mAb114 and REGN-EB3 superior to ZMapp in reducing mortality from Ebola virus disease.
The World Health Organization identified him as the inaugural president of the Congolese Academy of Science.